STOCKHOLM, SE / ACCESS Newswire / July 29, 2025 / AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing ...

It’s not too late to get started, and it doesn’t require becoming a pickleball champ or swearing off ice cream.

People with a developmental condition that's surging in the US may be at up to a three-fold greater risk of developing ...

The SHARE Program works with adults with early-stage dementia and their families to plan for the disease to progress.

Moderate coffee intake and both moderate and high tea consumption are associated with a slower decline in fluid intelligence ...

Explore how lifestyle changes in diet, exercise and social connections can improve brain health, delay cognitive decline and ...

Microglia, a type of brain immune cell, can gobble up amyloid beta protein, which clumps together into toxic aggregates ...

Phase 1 results demonstrate that SUL-238, a first-in-class, orally administered, mitochondria-directed drug candidate, is ...

Older adults who took medications for high blood pressure, high cholesterol and diabetes had slower rates of cognitive ...

If you need another reason to get your daily steps in, science has one for you. It has to do with your risk of getting ...

Families across Georgia are finding new hope in the fight against Alzheimer’s disease, thanks to promising treatments at ...

First large-scale trial shows structured lifestyle changes—diet, exercise, brain training—can measurably improve brain health ...